Development and acceptability of a decision aid for anxiety disorder considering discontinuation of benzodiazepine anxiolytic.

Yumi Aoki,Yoshikazu Takaesu,Ken Inada,Hiroki Yamada,Tomohiko Murao,Toshiaki Kikuchi,Masahiro Takeshima,Masayuki Tani,Kazuo Mishima,Tempei Otsubo

Frontiers in psychiatry（2023）

Cited 0|Views10

No score

Abstract

We successfully created a DA for individuals with anxiety disorders who consider tapering BZD anxiolytics, which was acceptable for both patients and healthcare providers. Our DA was designed to assist patients and healthcare providers to involve decision-making about whether to taper BZD anxiolytics or not.

Translated text

Key words

anxiolytic,anxiety disorder,benzodiazepine,decision aid,shared decision making

AI Read Science

Must-Reading Tree

Example

Generate MRT to find the research sequence of this paper

Chat Paper

Summary is being generated by the instructions you defined